New device offers hope for liver cancer patients out of options
NCT ID NCT07118202
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a device called TheraBionic P1 in people with advanced liver cancer who have already tried at least two other treatments or cannot take standard therapy. The goal is to see if the device can help them live longer and improve their quality of life. About 198 adults will use the device at home, and researchers will track survival, side effects, and how the cancer responds.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA RECURRENT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Karmanos Cancer Institute
RECRUITINGDetroit, Michigan, 48201, United States
-
Karmanos Cancer Institute at McLaren Bay Region
RECRUITINGBay City, Michigan, 48706, United States
-
Karmanos Cancer Institute at McLaren Central Michigan, Morey Cancer Center
RECRUITINGMount Pleasant, Michigan, 48858, United States
-
Karmanos Cancer Institute at McLaren Flint
RECRUITINGFlint, Michigan, 48532, United States
-
Karmanos Cancer Institute at McLaren Greater Lansing
RECRUITINGLansing, Michigan, 48910, United States
-
Karmanos Cancer Institute at McLaren Lapeer Region
RECRUITINGLapeer, Michigan, 48446, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.